Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on: January 16,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on:January 16,2024

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

by Brown UniversityCredit:Journal of Controlled Release(2022). DOI: 10.1016/j.jconrel.2022.10.051Researchers have demonstrated in mice a new approach for delivering medication across

Updated on: February 18,2024

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

by Brown UniversityCredit:Journal of Controlled Release(2022). DOI: 10.1016/j.jconrel.2022.10.051Researchers have demonstrated in mice a new approach for delivering medication across

Updated on:February 18,2024

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

Updated on: March 09,2024

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

Updated on:March 09,2024

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on: January 02,2024

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on:January 02,2024

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on: June 08,2024

Researchers define mechanism that causes kidney cancer to recur

by University of Texas Health Science Center at San AntonioNew research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans A

Updated on:June 08,2024

Study of first birth cohort to receive HPV vaccine shows the treatment works

by University of CopenhagenA tissue sample from a cervix with severe dysplasia (HSIL). Credit: University of CopenhagenCompared to a birth cohort from 1983, girls in the first birth cohort to rec

Updated on: March 06,2024

Study of first birth cohort to receive HPV vaccine shows the treatment works

by University of CopenhagenA tissue sample from a cervix with severe dysplasia (HSIL). Credit: University of CopenhagenCompared to a birth cohort from 1983, girls in the first birth cohort to rec

Updated on:March 06,2024

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado

Updated on: March 12,2024

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado

Updated on:March 12,2024

Moving the needle on monitoring skin cancer

by Benjamin Boettner,Harvard UniversityThe team engineered a strategy for monitoring the immunological responses to a newly devised, locally applied immunotherapy against melanoma. The therapy a

Updated on: February 01,2024

Moving the needle on monitoring skin cancer

by Benjamin Boettner,Harvard UniversityThe team engineered a strategy for monitoring the immunological responses to a newly devised, locally applied immunotherapy against melanoma. The therapy a

Updated on:February 01,2024

Researchers find new cancer gene drivers

by Bill Hathaway,Yale UniversityYale researchers exploring the structure of proteins have found evidence of how some genes drive the progression of cancer. Credit: Yale UniversityScientists have

Updated on: June 19,2024

Researchers find new cancer gene drivers

by Bill Hathaway,Yale UniversityYale researchers exploring the structure of proteins have found evidence of how some genes drive the progression of cancer. Credit: Yale UniversityScientists have

Updated on:June 19,2024

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Updated on: February 01,2024

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Updated on:February 01,2024

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma

by OncotargetElevated HDAC2 mRNA expression is poorly prognostic in DDLPS. (A) mRNA expression of HDAC2 and disease-free survival (DFS) data from 52 subjects with DDLPS from The Cancer Genome Atlas (T

Updated on: May 11,2024

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma

by OncotargetElevated HDAC2 mRNA expression is poorly prognostic in DDLPS. (A) mRNA expression of HDAC2 and disease-free survival (DFS) data from 52 subjects with DDLPS from The Cancer Genome Atlas (T

Updated on:May 11,2024

New method predicts the right treatment for breast cancer patients

byKarolinska InstitutetThe researchers developed and tested whole-tumor cell culture models derived from breast cancer patients that can predict how the tumors will respond to different treatmen

Updated on: January 13,2024

New method predicts the right treatment for breast cancer patients

byKarolinska InstitutetThe researchers developed and tested whole-tumor cell culture models derived from breast cancer patients that can predict how the tumors will respond to different treatmen

Updated on:January 13,2024